A Multicenter Study of the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin®) Plus 5-Fluorouracil/ Leucovorin in
Patients with Metastatic Colorectal Cancers that Have Progressed After Standard Chemotherapy
Oxaliplatin (NSC 266046) in Combination with 5-Fluorouracil and Leucovorin (FOLFOX4) for Patients Who Have Not Received Prior
Chemotherapy for Advanced Colorectal Cancer